A detailed history of Pathstone Holdings, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 6,968 shares of PTCT stock, worth $273,354. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,968
Previous 7,352 5.22%
Holding current value
$273,354
Previous $224,000 15.18%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$30.39 - $37.66 $11,669 - $14,461
-384 Reduced 5.22%
6,968 $258,000
Q2 2024

Aug 14, 2024

BUY
$24.69 - $40.12 $181,520 - $294,962
7,352 New
7,352 $224,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Pathstone Holdings, LLC Portfolio

Follow Pathstone Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pathstone Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pathstone Holdings, LLC with notifications on news.